Attention: You are using an outdated browser, device or you do not have the latest version of
Please download the latest software or switch device to avoid further issues.
Crick Lecture | Ugur Sahin, “Personalized cancer immunotherapy”
In person and online
Thursday 11 Apr 2024
4:00 PM - 5:00 PM
Sign up here
The CrickConnect team are delighted to be able to invite community members to join us for the institute's regular Crick Lecture.
Crick Lectures provide a broad insight into biomedical research from leading scientists. Not to be missed, the one-hour lectures are the event of the week for the Crick community to come together. The lectures aim to be accessible to scientists across different disciplines, while also offering something for the specialist.
There is also an opportunity to catch up with colleagues and friends over refreshments after Crick Lectures from 17:00. If you are able to join us in person at the Crick please let us know at firstname.lastname@example.org so we can arrange access.
We're delighted to welcome Professor Uğur Şahin, Co-Founder and CEO of BioNTech to give this week's Crick lecture.
Prof. Uğur Şahin, M.D.,Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel approaches to fight cancer and infectious diseases.
Şahin is one of the world’s foremost experts on messenger ribonucleic acid (mRNA) medicines. He has pioneered several fundamental breakthroughs enabling the development of mRNA vaccines and other types of immunotherapies. Sahin initiated and oversaw “Project Lightspeed,” the historic development of the first mRNA vaccine for COVID-19, moving from lab and clinical testing to conditional approval within an unprecedented 11-month period. He also leads BioNTech’s research and development of neoantigen specific as well as nonneoantigen specific mRNA cancer vaccines which can be individually tailored and produced on demand according to the profile of non-synonymous mutations identified by next-generation sequencing in patients’ tumors. Ugur Sahin is co-inventor of more than 500 filed patents applications and patents.
Şahin's academic credentials include serving as a Full Professor in Translational Oncology & Immunology at Johannes Gutenberg University in Mainz, Germany, where he was the supervisor of more than 50 PhD students. He also holds the role of Chairman of the Scientific Management Board of the Helmholtz Institute for Translational Oncology (HI-TRON). Based on his contributions to scientific discovery, Sahin has received numerous awards and recognitions, including the German Sustainability Award, the Mustafa Prize, and the German Cancer Award. He is married to Prof. Özlem Türec Co-Founder and CMO of BioNTech.
11 Apr 2024 4:00 PM - 5:00 PM
Due to the pioneering and sensitive nature of some of the research discussed in these lectures, only Crick Lectures from selected speakers will be shared, and we ask all attendees to respect the private nature of these talks by refraining from making any type of recording, sharing access details or in any other way compromising the research that is discussed.
If you'd like to attend in person please let us know at email@example.com
The Francis Crick Institute 1 Midland Road London NW1 1AT